Mustang Bio Inc (NAS:MBIO)
$ 0.19 -0.01 (-5%) Market Cap: 9.08 Mil Enterprise Value: 6.54 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Mustang Bio Inc at Chardan Genetic Medicines Conference (Virtual) Transcript

Oct 05, 2021 / 12:00PM GMT
Release Date Price: $35.25 (-4.47%)
Keay Nakae
Chardan Capital Markets - Analyst

Welcome to day two of Chardan's fifth annual genetic medicines conference. Our compliance department has asked us to read the following message before we get started. Ideas and recommendations presented are solely those of the presenter and not Chardan. Presenters have been advised not to discuss any confidential or material nonpublic information. Additionally, any KOL speaking may have investments or other interests in the names that they discussed.

With that out of the way, it's my pleasure to introduce our next guest from Mustang Bio, President and Chief Executive Officer, Dr. Manny Litchman; Chief Technical Officer, Dr. Knut Niss; VP -- Senior VP, Head of Clinical Development, Dr. Bruce Dezube; and Senior VP of Finance and Corporate Controller, Mr. Brian Achenbach.

The format for this session is a roughly 25-minute fireside chat. If any of our audience attendees have questions during the session, feel free to type them into the question box under the video player, and we will try to ask them on your behalf.

So with that,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot